Vascular aneurysms: A side-splitting affair

Cardiovascular Research

Volumn 31, Issue 2, 1996, Pages 222-230

  Herron, G Scott ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; HUMAN; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SHORT SURVEY; ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; REVIEW;

ADULT; AORTIC ANEURYSM, ABDOMINAL; FEMALE; HUMANS; MALE; MIDDLE AGED; AORTA; ENDOPEPTIDASES; EXTRACELLULAR MATRIX;

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

EID: 0029873765     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00080-1     Document Type: Review

References (52)

1. Webster MW. The inheritance and screening program in aoritc aneurysm. In: JST Yao, WH Pearse, eds. Aneurysms: New Findings and Treatments. Norwalk, CT: Appleton and Lange, 1994: 63.
2. Anidjar S, Kieffer E. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann Vasc Surg 1992;6:298-305.
3. Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Arch Surg 1984;119:405-409.
4. White JV, Haas K, Phillips S, et al. Advential elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-381.
5. Baxter BT, Halloran BG. Matrix protein metabolism in abdominal aortic aneurysms. In: JST Yao, WH Pearse, eds. Aneurysms: New Findings and Treatments. Norwalk, CT: Appleton and Lange, 1994: 25-34.
6. Francke U, Furthmayr H. Genes and gene products involved in Marfan syndrome. Semin Thorac Cardiovasc Surg 1993;5:3-10.
7. Pereira L, Levran O, Ramirez F, et al. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med 1994;331(3):148-153.
8. Berg MA, Tynan K, Aoyama T. Aortic aneurysm in a family with a glycine-to-serine substitution in the FBN-1 gene. Am J Hum Genet 1993;53(Suppl):151(abstr).
9. Curran ME, Atkinson DL, Ewart AK, et al. The elastin gene is distrupted by a translocation associated with supravalvular aortic stenosis. Cell 1993;73:159-168.
10. Ewart AK, Jan W, Atkinson D, et al. Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J Clin Invest 1994;93:1071-1077.
11. Kuivaniemi H, Tromp G, Prockop D. Genetic causes of aortic aneurysms. J Clin Invest 1991;88:1441-1444.
12. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
13. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 1988;948:67-85.
14. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
15. Busuttil RW, Rinderbreicht H, Flesher A, et al. Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res 1982;32:214-217.
16. Cannon DJ, Read RC. Blood elastolytic activity in patients with aortic aneurysm. Ann Thorac Surg 1982;32:214-217.
17. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
18. Herron GS, Unemori E, Wong M, et al. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Aterioscler Thromb 1991;11:1667-1677.
19. Jean-Claude J, Newman K, Li H, et al. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 1994;116:472-478.
20. Reilly J, Sicard G, Lucore C. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994;19:865-872.
21. Cohen JR, Mandell C, Margolis I, et al. Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms. Surg Gynecol Obstet 1987;164:355-358.
22. Cohen JR, Sarfati I, Ramer L, et al. Alpha 1-antitrypsin phenotypes in patients with abdominal aortic aneurysms. J Surg Res 1990;49:319-321.
23. Mitchell MB, McAnena OJ, Rutherford RB. Ruptured mesenteric artery aneurysm in a patient with alpha 1-antitrypsin deficiency: etiologic implications. J Vasc Surg 1993;17:420-424.
24. Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in athersclerotic human arteries. Proc Natl Acad Sci USA 1992;89:6998-7002.
25. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
26. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive cells. Nature 1994;370:61-65.
27. Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72 kDa type IV collagenase: isolation of the activated form of the membrane metalloproteinase. J Biol Chem 1995;270:5331-5338.
28. Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci 1991;81:233-239.
29. Irizarry E, Newman RM, Gandhi RH, et al. Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 1993;54:571-574.
30. Tilson MD, Newman KA. Proteolytic mechanisms in the pathogenesis of aortic aneurysms. In: J.S.T. Yao and W.H. Pearse, eds. Aneurysms: New Findings and Treatments. Norwalk, CT: Appleton and Lange, 1994: 3-10.
31. Tilson MD, Reilly JM, Brophy CM, et al. Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 1993;18:266-270.
32. Chu CT, Oury TD, Enghild JJ, et al. Adjuvant-free in vivo targeting. J Immunol 1994;152:1538-1545.
33. Zarins CK, Glagov S. Atherosclerotic process and aneurysm formation. In: J.S.T. Yao and W.H. Pearse, eds. Aneurysms: New Find-ings and Treatments. Norwalk, CT: Appleton and Lange, 1994: 35-48.
34. Cohen JR, Sarfati I, Danna D, et al. Smooth muscle cell elastase, athersclerosis and abdominal aortic aneurysms. Ann Surg 1992;216:327-330.
35. Francke U, Furthmayr H. Marfan's syndrome and other disorders of fibrillin. N Engl J Med 1994;330:1384-1385.
36. Koch AE, Haines GR, Rizzo RJ, et al. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990;137:1199-1219.
37. Louwrens H, Pearse WH. Role of inflammatory cells in aortic aneurysms. In: J.S.T. Yao and W.H. Pearse, eds. Aneurysms: New Findings and Treatments. Norwalk, CT: Appleton and Lange, 1994: 11-24.
38. Ramshaw AL, Parums DV. The distribution of adhesion molecules in chronic periaortitis. Histopatholology 1994;24:23-34.
39. Tanaka S, Komori K, Okadome K, et al. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg 1994;20:235-43.
40. Koch AE, Kunkel SL, Pearse WH, et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993;142:1423-1431.
41. Brophy CM, Reilly JM, Smith GJW, et al. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg 1991;5:229-233.
42. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Op Cell Biol 1989;1:974-982.
43. Unemori EN, Mauch C, Hoeffler WK, et al. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1. Exp Cell Res 1994;211:212-218.
44. Tremble PM, Lane TF, Sage EH, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993;121:1433-1444.
45. Barger AC, Beeuwkes R, Lainey LL, et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984;310(3):175-177.
46. Kahlon R, Shapero J, Gotlieb AI. Angiogenesis in atherosclerosis. Can J Cardiol 1992;8:60-64.
47. Zhang Y, Cliff WJ, Schoefl GI, et al. Immunohistochemical study of intimai microvessels in coronary atherosclerosis. Am J Pathol 1993;143(1):164-172.
48. Zollikofer CL, Redha FH, Bruhlmann WF, et al. Acute and long-term effects of massive balloon dilation on the aortic wall and vasa vasorum. Radiology 1987;164:145-149.
49. Okuyama K, Yaginuma G, Takahashi T, et al. The development of vasa vasorum of the human aorta in various conditions: a morphometric study. Arch Pathol Lab Med 1988;112:726-730.
50. Schmitt-Graff A, Desmoulière A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchow Arch 1994;425:3-24.
51. Brown PD. Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer. Ann NY Acad Sci 1994;732:17-21.
52. Dubick MA, Hunter GC, Perez-Lizano E, et al. Assessment of the role of pancreatic proteases in human abdominal aortic aneurysms and occlusive disease. Clin Chem Acta 1988;177:1.